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CASE REPORT
Rhodococcus equi INFECTION AFTER REDUCTION MAMMAPLASTY 
IN AN IMMUNOCOMPETENT PATIENT
Uriel SANDKOVSKY(1), Gabriel SANDKOVSKY(2), Emilia M. SORDILLO(2,3) & Bruce POLSKY(2)
SUMMARY
The majority of infections caused by R. equi occur in hosts with some degree of cell-mediated immunodeficiency. Immunocompetent 
individuals are infrequently affected and usually present with localized disease. Infections of the skin or related structures are uncommon 
and are usually related to environmental contamination. The microbiology laboratory plays a key role in the identification of the 
organism since it may be mistaken for common skin flora. We describe a 31 year-old woman without medical problems who presented 
nine weeks after breast reduction with right breast cellulitis and purulent drainage from the surgical wound. She underwent incision 
and drainage, and cultures of the wound yielded Rhodococcus equi. The patient completed six weeks of antimicrobial therapy with 
moxifloxacin and rifampin with complete resolution. 
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INTRODUCTION
R. equi is a pleomorphic facultative, intracellular, nonmotile, 
non-spore forming, gram-positive coccobacillus that can be weakly 
acid-fast. It appears coccoid on solid media and in clinical specimens, 
but in liquid media it forms long rods or short filaments. Although it 
is named for its production of red pigment, cultures need 4 - 7 days to 
demonstrate the salmon pink colonies. It is an intracellular pathogen and 
the basis for its pathogenicity is its ability to survive inside macrophages, 
causing inflammation, cell destruction, and purulent granulomas with 
progression to caseating necrosis. Histopathology shows necrotizing 
granulomas with macrophages, or an unusual chronic granulomatous 
inflammatory process that is associated with an impaired ability to process 
microorganisms within histiocytes called malacoplakia9,17. The majority 
of the Rhodococcus infections occur in immunocompromised individuals, 
most commonly in patients with impaired cell mediated immunity (e.g. 
leukemia, lymphoma, HIV infection, solid organ transplant recipients, 
etc); two-thirds of reported case have occurred in patients with HIV 
infection9,11,17. For reasons that are not clear, the male to female ratio 
is 3:1 for both immunocompetent and immunocompromised patients7. 
Skin manifestations are rare even in immunocompromised hosts1, and 
only a few cases of skin infections, including abscesses, caused by 
Rhodococcus among immunocompetent patients have been reported. 
Soil contamination was determined to be the predisposing factor in two 
cases (one cured with surgical debridement alone and the other with 
antimicrobial therapy), in one case the predisposing source was unknown 
(cure was achieved with antimicrobials and surgical debridement), 
and in one case, scalp infection was determined to be caused by self-
inoculation3,5,10,12. We present the first report of skin infection with 
Rhodococcus equi after breast reduction surgery.
CASE REPORT
A 31 year old Hispanic female patient without previous medical 
problems presented to St. Luke’s-Roosevelt Hospital Center with a 10 
day history of erythema, swelling and induration over her right breast, 
accompanied by purulent discharge. Although she recalled having chills 
and subjective fever; no temperature was recorded. She denied other 
systemic symptoms including, chest pain, and shortness of breath, 
abdominal pain, nausea, vomiting, or\ diarrhea. She had traveled to the 
Dominican Republic three months earlier in order to have bilateral breast 
reduction mammaplasty and abdominoplasty. She stayed in the city and 
did not visit any rural areas during the whole stay. She and her sister went 
together and both had the same surgical procedure performed without 
immediate postoperative complications. The patient recalled performing 
the indicated postoperative care (which she said only consisted of dry 
dressing changes until stitches were removed) and denied insect bites 
or any contact with animals. Six weeks after the procedure, she noticed 
purulent discharge from the abdominoplasty scar. She was seen by a local 
physician, who diagnosed a postsurgical wound infection and prescribed 
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ciprofloxacin 500 mg orally twice daily for 10 days long with local 
wound care. Routine aerobic wound cultures taken at that time revealed 
no pathogens, and her symptoms resolved after the administration of 
antimicrobial therapy. Approximately nine weeks after the surgery, 
the patient developed tenderness and purulent discharge from the right 
breast incision and came to our institution for further evaluation. The 
patient was not in any distress, her vital signs were unremarkable and 
temperature was normal. Examination revealed a 3 x 1 cm erythematous 
and indurated area with purulent discharge over the surgical scar on 
her right breast (Fig. 1). The area was warm and tender to touch. The 
abdominal scar showed no erythema or drainage. Initial laboratory results 
showed a white blood cell count of 8.4 K/µL (70% neutrophils); the rest 
of the complete blood count as well as blood chemistries were normal. 
The patient underwent incision and drainage. Gram stain of the operative 
specimen showed gram-positive coccobacili that were partially acid-fast 
bacteria on modified Kinyoun stain. Small colonies were appreciated on 
solid media (blood and chocolate agars) at 24 hours, and after four days 
developed into salmon-pink color colonies. Growth was also observed 
on Middlebrook 7H10 agar although no mycobacteria were isolated. 
Gram stain performed on the Middlebrook 7H10 agar growth, showed 
branching filamentous gram-positive rods that were also modified acid-
fast positive. The organism, which was catalase-positive and nonmotile, 
was identified as Rhodococcus equi using a RapIDTM CB Plus system 
(Remel Products, Thermo Fisher Scientific, Kansas, USA), used to 
identify medically important coryneform bacteria and gram positive 
bacilli. The organism was susceptible to ciprofloxacin, moxifloxacin, 
erythromycin, rifampin, imipenem, vancomycin and gentamicin. A 
combination of oral moxifloxacin 400 mg and rifampin 600 mg, both 
daily, was begun. Serologic evaluation for anti-human immunodeficiency 
virus (HIV) antibody test was negative by ELISA testing. The patient’s 
wound infection resolved without complications and antimicrobials were 
stopped after a total of six weeks. She has been without recurrence for 
more than four years, and continues to follow up periodically in clinic.
DISCUSSION
R. equi lives in soil and it is found in 50-95% of farms. Concentrations 
are high in horse manure and it is carried in the gut of many herbivores. 
Infection is primarily acquired through the respiratory tract, but it 
can also be acquired by the oral route and by traumatic inoculation 
or superinfection of wounds3,10,12,17. Nosocomial cases have been only 
reported in immunocompromised patients and one case of occupational 
acquisition by a healthy laboratory worker who developed pneumonia 
has also been described4,16. Our patient did not recall any other exposure 
other that the surgical intervention, she denied having visited farms or 
having contact with animals.
The incidence of infections due to R. equi increased markedly in 
the early eighties, probably related to the HIV epidemic, advances in 
chemotherapy for patients with cancer, organ transplantation and also 
improvements in microbiology laboratory identification techniques9,17.
Immunocompetent patients tend to have localized disease 
whereas infections can be disseminated in patients with underlying 
immunodeficiency. Pneumonia is the most common manifestation 
with most patients showing radiological evidence of cavitation. Other 
manifestations include lymphadenitis, endophthalmitis, musculoskeletal 
Fig. 1 - Right breast showing erythema on the lower quadrants and a crusted area over the 
surgical scar which drained purulent material.
Table 1
Summary of the reported cases of skin infections caused by Rhodococcus in immunocompetent patients
Authors Age (years) and 
gender
Possible predisposing 
factors
Localization Treatment Outcome 
CASTOR, et al.3 35, female Self inoculation Leg ulcer Multiple antimicro-
bial courses
Relapsed with repeated 
infections and multiple 
pathogens
GARCIA MORILLO, 
et al.5
76, female Unknown Left thigh, abscesses Surgical debridement 
plus Ciprofloxacin 
and rifampin
Cured
MULLER, et al.10 13, male Soil contamination Knee and foot Surgical debridement 
and irrigation. No 
antimicrobials
Cured
NASSER, et al.12 16, male Soil contamination Scalp Erythromycin and 
rifampin
Cured
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and central nervous system infections. Indwelling catheter infections and 
a liver abscess have also been described. Bacteremia occurs in 30% of 
normal hosts but in up to 80% of immunocompromised patients. Relapses 
are a well-known feature manifesting at the initial site of the disease or 
at distant locations6,7,9,16,17.
Since R. equi is not a common pathogen, a high index of suspicion 
is required or the diagnosis may be easily missed. Identification of the 
organism from microbiological specimens is the method of choice. 
The organism grows easily but may be dismissed as a contaminant, so 
laboratory personnel should be notified if R. equi is suspected (e.g., 
immunocompromised patients with cavitary pneumonia). The organism 
has been isolated from virtually any site17. 
The isolation of Rhodococcus in our patient’s wound culture was both 
striking and unexpected as a cause of wound infection. In a retrospective 
series, more than half of the skin infections after breast surgery were 
caused by Staphylococcus aureus, followed by Pseudomonas aeruginosa, 
Mixed flora, Coagulase-negative staphylococci, Enteric gram negative 
rods and Streptococus viridans group14. Apart from common skin 
pathogens, cases of nontuberculous mycobacterial infections (especially 
Mycobacterium fortuitum) complicating augmentation mammaplasty and 
breast reconstruction have been reported, but more recently M. fortuitum 
and Mycobacterium chelonae were also cultured from patients who 
underwent reduction mammaplasty 2,8,15.
Most cases reported in the literature occurred following contamination 
of the skin or soft tissues1,3,5,10,12,17. Although we considered soil 
contamination as the likely source for infection in our patient, we initially 
saw her several weeks after the surgery was performed so we were unable 
to prove it. Table 1 summarizes the reported cases of skin infections 
caused by Rhodococcus in immunocompetent patients.
Guidelines or standards for treatment of R. equi have not been 
established due to the small number of reported cases. Single antimicrobial 
therapy has proven ineffective therefore is not recommended. The use 
of combination therapy with two to three antibiotics is the mainstay of 
treatment, along with surgical drainage of large cavities and abscesses. 
Because R. equi is an intracellular organism and can survive inside 
macrophages some authors have advocated treatment with drugs that 
achieve high intracellular concentrations; this statement is, however, 
unclear with others just advocating the use of bactericidal drugs in the 
initial phase of therapy9,17. 
R. equi is usually resistant to penicillins and, even when susceptible, 
their use is not recommended due to the rapid emergence of resistance7. 
Preferred antimicrobials based on in-vitro susceptibilities include 
imipenem, vancomycin, linezolid, fluoroquinolones, erythromycin, 
rifampin and the aminoglycosides. Clindamycin, the tetracyclines, 
chloramphenicol, trimethoprim-sulfamethoxazole and cephalosporins 
have variable in vitro susceptibility and should not be use as first line 
agents. In an animal model, the most effective agents were vancomycin, 
imipenem, and rifampin13. Our patient was treated with a combination 
of rifampin and moxifloxacin (both achieve excellent intracellular 
concentrations), showing resolution of symptoms.
Localized infections can usually be treated with oral antimicrobials 
and therapy should be continued until clinical improvement occurs with 
resolution of signs and symptoms. The prognosis of patients with normal 
immune function is usually favorable9,17. No data is available regarding 
prognosis in patients with localized skin infections like ours.
This case illustrates the importance performing appropriate cultures 
before the administration of antimicrobial therapy and also the key 
role of the microbiology laboratory in the identification of uncommon 
pathogens. To our knowledge this is the first case of R. equi following 
reduction mammaplasty described in the literature.
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RESUMEN
Infección por Rhodococcus equi luego de cirugía de reducción 
mamaria en huésped inmunocompetente
La mayoría de las infecciones causadas por Rhodococcus equi 
ocurren en huéspedes con algún grado de inmunodeficiencia celular. 
Los individuos inmunocompetentes son afectados con baja frecuencia y 
suelen presentarse con enfermedad localizada. Las infecciones de la piel 
o partes blandas son poco frecuentes y están usualmente relacionadas 
con contaminación ambiental. El laboratorio de microbiología juega 
un papel clave en la identificación del organismo, ya que este puede 
confundirse con flora normal de la piel. Se describe una mujer de 31 años 
sin problemas médicos que consultó nueve semanas después de haber sido 
sometida a cirugía de reducción mamaria, con celulitis del seno derecho 
y drenaje purulento de la herida quirúrgica. Se practicó incisión y drenaje 
quirúrgico y los cultivos de la herida demostraron R. equi. La paciente 
recibió seis semanas de tratamiento antimicrobiano con moxifloxacina 
y rifampicina demostrando resolución completa.
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